Women's health is a field of medicine that focuses on the treatment and diagnosis of disorders that affect a woman's physical and mental health. It includes all treatments, medications, and surgical products for disorders affecting women. Due to biological, social, and behavioural differences, women's health and disease differ from men's. Various women disorders are, nutrition disorders, reproductive health disorders, menopause and menstrual cycle related disorders among others. The focus of women's health is on improved disease management and increasing or enhancing the overall health of the female population.
MARKET SCOPE
The "Global Women Health Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Women health market with detailed market segmentation by product type, treatment type, diagnosis, disease indication and end user. The report provides key statistics on the market status of the leading Women health market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type the market is segmented as, devices, drugs, pharmaceutical pipeline.
- Based on treatment type the market is segmented as, hormonal treatment, non-hormonal treatment, surgery.
- Based on the diagnosis the market is segmented as, diagnostic imaging test, biopsis, ovulation testing, others.
- Based on disease indication the market is segmented as, cancer, reproductive health, post- menopausal syndrome, urological disorders.
- Based on the end user the market is segmented as, hospitals, clinics, gynecology centers, research institutes, others.
MARKET DYNAMICS
Drivers:
- Increasing prevalence of gynecological disorders and other diseases affecting principally to women.
- Increasing awareness about women health.
- Increasing initiatives by government to promote women health and spreading awareness about women health.
- Rising R&D activities from pharmaceutical companies to develop and launch innovative therapies for management of women disorders.
- Presence of robust pipeline of therapeutic drugs.
Restraints:
- Whereas, possible side effects from drug therapies and lack of awarness about women health in some developing nations are expected to hamper market growth.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Women health market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Women health market in these regions.
IMPACT OF COVID-19 ON WOMEN HEALTH MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Women health market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Women health market are anticipated to lucrative growth opportunities in the future with the rising demand for Women health in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Women health market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Eli Lilly and Company
- Agile Therapeutics
- Pfizer Inc
- Merck Sharp and Dohme Corp
- Ferring B.V
- Amgen Inc
- Mylan N.V. (Viatris)
- Abbott
- F. Hoffmann-La Roche Ltd
- Blairex Laboratories, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.